This white paper reviews opportunities and challenges in the alternate protein markeplace, including the role for microbiome analysis in determining the health impact of new products. It highlights the role for AI-augmented system science to leverage multidimensional data sets to understand host-microbiome interactions and expedite new product development with desired end-user benefits evaluation of alternative proteins as possible.